Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
26 February 2025 - 7:14AM
Edgar (US Regulatory)
Citigroup Global Markets Holdings Inc.
Fully and Unconditionally Guaranteed by Citigroup
Inc.
|
 |
Term
Sheet No. 2025-USNCH25953
dated
February 24, 2025 relating to
Preliminary Pricing Supplement No. 2025-USNCH25953
dated
February 24, 2025
Registration Statement Nos.
333-270327 and 333-270327-01
Filed Pursuant to Rule 433 |
Market Linked Securities—Auto-Callable with Contingent
Coupon and Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing
of the SPDR® S&P® Biotech ETF, the Utilities Select Sector SPDR® Fund and the VanEck®
Semiconductor ETF due March 10, 2028
Term Sheet to Preliminary Pricing Supplement No. 2025-USNCH25953
dated February 24, 2025
|
Summary
of Terms
Issuer
and Guarantor: |
Citigroup
Global Markets Holdings Inc. (issuer) and Citigroup Inc. (guarantor) |
Underlyings: |
The
SPDR® S&P® Biotech ETF, the Utilities Select Sector SPDR® Fund and the VanEck®
Semiconductor ETF (each an “underlying” and collectively the “underlyings”) |
Pricing
Date*: |
March
7, 2025 |
Issue
Date*: |
March
12, 2025 |
Stated
Principal Amount: |
$1,000
per security |
Contingent
Coupon: |
On
each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon at a per annum rate
equal to the contingent coupon rate if and only if the closing value of the lowest performing underlying on the immediately
preceding calculation day is greater than or equal to its coupon threshold value. Each “contingent coupon payment,” if
any, will be calculated per security as follows: ($1,000 × contingent coupon rate)/4. Any contingent coupon payment will be
rounded to the nearest cent, with one-half cent rounded upward. |
Contingent
Coupon Rate: |
At
least 12.50% per annum (to be determined on the pricing date). |
Contingent
Coupon Payment Dates: |
The
third business day after each calculation day, except that the contingent coupon payment date following the final calculation day
will be the maturity date. |
Automatic
Early Redemption: |
If,
on any potential autocall date, the closing value of the lowest performing underlying is greater than or equal to its starting value,
each security you then hold will be automatically redeemed on the immediately following contingent coupon payment date for an amount
in cash equal to $1,000 plus the related contingent coupon payment. |
Calculation
Days*: |
The
7th day of each March, June, September and December, beginning in June 2025 and ending in March 2028, provided that the March
2028 calculation day will be the final calculation day. |
Final
Calculation Day*: |
March
7, 2028 |
Potential
Autocall Dates*: |
Each
calculation day beginning in September 2025 and ending in December 2027. |
Maturity
Payment Amount (per security): |
• if
the closing value of the lowest performing underlying on the final calculation day is greater than or equal to its downside
threshold value: $1,000; or
• if
the closing value of the lowest performing underlying on the final calculation day is less than its downside threshold value:
$1,000
× the performance factor of the lowest performing underlying on the final calculation day
|
Maturity
Date*: |
March
10, 2028 |
Lowest
Performing Underlying: |
For
any calculation day, the underlying with the lowest performance factor determined as of that calculation day |
Performance
Factor: |
For
each underlying on any calculation day, its closing value on that calculation day divided by its starting value |
Starting
Value: |
For
each underlying, its closing value on the pricing date |
Coupon
Threshold Value: |
For
each underlying, 70% of its starting value |
Downside
Threshold Value: |
For
each underlying, 70% of its starting value |
Calculation
Agent: |
Citigroup
Global Markets Inc. (“CGMI”), an affiliate of Citigroup Global Markets Holdings Inc. |
* subject to change |
Summary
of Terms (continued)
Denominations: |
$1,000
and any integral multiple of $1,000 |
Agent
Discount**: |
Up
to 2.325%; dealers, including those using the trade name Wells Fargo Advisors (“WFA”), may receive a selling concession
of 1.75% and WFA may receive a distribution expense fee of 0.075%. |
CUSIP
/ ISIN: |
17333H2X1
/ US17333H2X19 |
United
States Federal Tax Considerations: |
See
the preliminary pricing supplement. |
** In addition,
CGMI may pay a fee of up to 0.30% to selected securities dealers in consideration for marketing and other services in connection with
the distribution of the securities to other securities dealers.
Hypothetical
Payout Profile (maturity payment amount)

If
the closing value of the lowest performing underlying on the final calculation day is less than its downside threshold value, you will
receive significantly less than the stated principal amount of your securities, and possibly nothing, at maturity, and you will not receive
any contingent coupon payment at maturity.
You
will not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on
the securities will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on
any underlying over the term of the securities.
On
the date of the related preliminary pricing supplement, Citigroup Global Markets Holdings Inc. expects that the estimated value of the
securities on the pricing date will be at least $908.00 per security, which will be less than the public offering price. The estimated
value of the securities is based on CGMI’s proprietary pricing models and Citigroup Global Markets Holdings Inc.’s internal
funding rate. It is not an indication of actual profit to CGMI or other of Citigroup Global Markets Holdings Inc.’s affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any
time after issuance. See “Valuation of the Securities” in the accompanying preliminary pricing supplement.
Preliminary Pricing
Supplement:
https://www.sec.gov/Archives/edgar/data/200245/000095010325002358/dp225262_424b2-us2548081d.htm
The
securities have complex features and investing in the securities involves risks not associated with an investment in conventional debt
securities. See “Summary Risk Factors” in this term sheet and the accompanying preliminary pricing supplement and “Risk
Factors” in the accompanying product supplement.
This
introductory term sheet does not provide all of the information that an investor should consider prior to making an investment decision.
Investors
should carefully review the accompanying preliminary pricing supplement, product supplement, underlying supplement, prospectus supplement
and prospectus before making a decision to invest in the securities.
NOT A BANK DEPOSIT
AND NOT INSURED OR GUARANTEED BY THE FDIC OR ANY OTHER GOVERNMENTAL AGENCY
|
Summary
Risk Factors
The
risks set forth below are discussed in detail in the “Summary Risk Factors” section in the accompanying preliminary pricing
supplement and the “Risk Factors” section in the accompanying product supplement. Please review those risk disclosures carefully.
| · | You May Lose Some Or All Of Your Investment. |
| · | You Will Not Receive Any Contingent Coupon On The Contingent Coupon Payment
Date Following Any Calculation Day On Which The Closing Value Of The Lowest Performing Underlying Is Less Than Its Coupon Threshold Value. |
| · | Higher Contingent Coupon Rates Are Associated With Greater Risk. |
| · | The Securities Are Subject To Heightened Risk Because They Have Multiple
Underlyings. |
| · | The Securities Are Subject To The Risks Of Each Of The Underlyings And
Will Be Negatively Affected If Any One Underlying Performs Poorly, Regardless Of The Performance Of Any Other Underlying. |
| · | You Will Not Benefit In Any Way From The Performance Of Any Better Performing
Underlying. |
| · | You Will Be Subject To Risks Relating To The Relationship Between The
Underlyings. |
| · | You Will Not Receive Dividends Or Have Any Other Rights With Respect To
The Underlyings. |
| · | You May Not Be Adequately Compensated For Assuming The Downside Risk Of
The Lowest Performing Underlying. |
| · | The Securities May Be Automatically Redeemed
Prior To Maturity, Limiting Your Opportunity To Receive Contingent Coupon Payments. |
| · | The Securities Offer Downside Exposure To The Lowest Performing Underlying,
But No Upside Exposure To Any Underlying. |
| · | The Performance Of The Securities Will Depend On The Closing Values Of
The Underlyings Solely On The Calculation Days, Which Makes The Securities Particularly Sensitive To Volatility In The Closing Values
Of The Underlyings. |
| · | The Securities Are Subject To The Credit Risk Of Citigroup Global Markets
Holdings Inc. And Citigroup Inc. |
| · | The Securities Will Not Be Listed On Any Securities Exchange And You May
Not Be Able To Sell Them Prior To Maturity. |
| · | The Estimated Value Of The Securities On The Pricing
Date, Based On CGMI’s Proprietary Pricing Models And Our Internal Funding Rate, Is Less Than The Public Offering Price. |
| · | The Estimated Value Of The Securities Was Determined For Us By Our Affiliate
Using Proprietary Pricing Models. |
| · | The
Estimated Value Of The Securities Would Be Lower If It Were Calculated Based On Wells Fargo’s Determination Of The Secondary Market
Rate With Respect To Us. |
| · | The
Estimated Value Of The Securities Is Not An Indication Of The Price, If Any, At Which Any Person May Be Willing To Buy The Securities
From You In The Secondary Market. |
| · | The Value Of The Securities Prior To Maturity Will Fluctuate Based On
Many Unpredictable Factors. |
| · | We Have Been Advised That, Immediately Following Issuance, Any Secondary
Market Bid Price Provided By Wells Fargo, And The Value That Will Be Indicated On Any Brokerage Account Statements Prepared By Wells Fargo
Or Its Affiliates, Will Reflect A Temporary Upward Adjustment. |
| · | The SPDR® S&P® Biotech ETF Is Subject
To Risks Associated With Investing In The Biotechnology Sector. |
| · | The SPDR® S&P® Biotech ETF Is Subject
To Risks Associated With The Health Care Sector. |
| · | The Utilities Select Sector SPDR® Fund Is Subject To Concentrated
Risks Associated With The Utilities Sector. |
| · | The VanEck® Semiconductor ETF Is Subject To Risks Associated
With The Semiconductor Production And Equipment Sector. |
| · | Our Offering Of The Securities Is Not A Recommendation Of Any Underlying.
|
| · | The Closing Value Of An Underlying May Be Adversely Affected By Our Or
Our Affiliates’, Or By Wells Fargo And Its Affiliates’, Hedging And Other Trading Activities. |
| · | We And Our Affiliates And Wells Fargo And Its Affiliates May Have Economic
Interests That Are Adverse To Yours As A Result Of Our And Their Respective Business Activities. |
| · | The Calculation Agent, Which Is An Affiliate Of Ours, Will Make Important
Determinations With Respect To The Securities. |
| · | The Securities Will Not Be Adjusted For All Events That Could Affect The
Value Of The Shares Of Any Underlying. |
| · | If A Reorganization Event Occurs With Respect To An Underlying, The Calculation
Agent May Make Adjustments To The Terms Of The Securities That Adversely Affect Your Return On The Securities. |
| · | The Value And Performance Of The Shares Of An Underlying May Not Completely
Track The Performance Of The Underlying Index That The Underlying Seeks To Track Or The Net Asset Value Per Share Of The Underlying. |
| · | Changes That Affect The Underlyings May Affect The Value Of Your Securities. |
| · | A Contingent Coupon Payment Date And The Stated Maturity Date May Be Postponed
If A Calculation Day is Postponed. |
| · | The U.S. Federal Tax Consequences Of An Investment In The Securities Are
Unclear. |
|
Citigroup
Global Markets Holdings Inc. and Citigroup Inc. have filed a registration statement (including a related preliminary pricing supplement,
an accompanying product supplement, underlying supplement, prospectus supplement and prospectus) with the Securities and Exchange
Commission (“SEC”) for the offering to which this communication relates. You should read the related preliminary pricing
supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus in that registration
statement (File Nos. 333-270327 and 333-270327-01) and the other documents Citigroup Global Markets Holdings Inc. and Citigroup
Inc. have filed with the SEC for more complete information about Citigroup Global Markets Holdings Inc., Citigroup Inc. and this
offering. You may get these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, you
can request the related preliminary pricing supplement, accompanying product supplement, underlying supplement, prospectus supplement
and prospectus by calling toll-free 1-800-831-9146.
Wells
Fargo Advisors is a trade name used by Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC, members SIPC,
separate registered broker-dealers and non-bank affiliates of Wells Fargo Finance LLC and Wells Fargo & Company.
|
Citigroup (NYSE:C)
Historical Stock Chart
From Jan 2025 to Feb 2025
Citigroup (NYSE:C)
Historical Stock Chart
From Feb 2024 to Feb 2025